BUY SIDE BRO

BETANASDAQ ETF UNITS [NDQ] NDQ.AX

Latest Deep Dive · Written · AI research note

Bro's Verdict
Deep Dive

Rating

HOLD

Confidence

60%

Target Price

A$64.00

Upside

+0.6%

Horizon

medium

NDQ is a high quality, liquid vehicle for the global AI and mega cap tech theme, but at $63.61 it sits near the top of its 52-week range on a ~28x-30x forward multiple, so forward returns now depend on earnings delivery rather than multiple expansion. The analyst's 12-month fair value range of $60-$68 brackets the current price, implying negligible upside, and explicitly frames this as a hold rather than a chase. Accumulation is recommended only on weakness toward $55-$58, with unhedged USD exposure adding a second variable for AUD investors.

Executive Summary

•NDQ is a passive, currency unhedged tracker of the Nasdaq 100, giving ASX investors direct exposure to the world's dominant mega cap technology and AI franchise, with 58.2% of the portfolio in Information Technology and 13.7% in Communication Services.
•Fund size has scaled to ~$9.8b, making it one of the largest exchange traded products on the ASX, a scale advantage that supports tight tracking and deep secondary liquidity.
•Trailing performance remains strong: +16.7% YTD, +16.4% over 1 year and +23.8% annualised over 3 years, though the drift from the $65.18 high to $63.61 signals momentum has cooled into a higher rate and valuation sensitive tape.
•The core debate is valuation, not quality: the underlying index trades at ~28x to 30x forward earnings, so forward returns now hinge on AI monetisation and earnings delivery rather than multiple expansion.

Financial Snapshot

•Price: $63.61
•52 week range: $49.14 to $65.18
•Fund size (AUM): ~$9.8b
•YTD return: +16.7%
•1 year return: +16.4%
•3 year return: +23.8% annualised
•Distribution yield: low, approx 0.5% to 1.0% (Not disclosed precisely)
•Management cost: approx 0.48% p.a.
•Sector weight, Information Technology: 58.2%
•Sector weight, Communication Services: 13.7%
•Sector weight, Consumer Discretionary: 11.2%
•Sector weight, Consumer Staples: 6.6%
•Sector weight, Health Care: 3.8%
•Currency exposure: unhedged USD (AUD investor carries FX risk)

Forward Outlook

•Revenue growth of the underlying index: mid to high single digit to low double digit, driven by cloud, AI infrastructure and digital advertising (Not disclosed at fund level).
•EPS trajectory: consensus expects low double digit earnings growth for the Nasdaq 100 over the next 12 months, the key support for the current multiple.
•Margin trajectory: mega cap operating margins remain elevated, though AI capex is a rising depreciation drag into FY27.
•Distribution: estimated annual distribution component information flagged in July 2026, payout remains modest given the growth tilt.
•Fund flows: units on issue disclosures through September 2026 point to continued but moderating creations.
•FX: unhedged structure means AUD strength is a direct headwind to reported returns.

Valuation Analysis

•NTM P/E of underlying index: approx 28x to 30x (forward)
•NTM P/S of underlying index: approx 6x to 7x (forward)
•NTM EV/EBIT of underlying index: approx 22x to 24x (forward)
•Trailing (TTM) P/E of underlying index: approx 33x to 35x
•Fund level P/E and P/S: Not disclosed as a standalone metric
•PEG on the index: approx 2.0x to 2.5x, a premium to broad market
•Premium to S&P 500 forward multiple: approx 25% to 30%
•Fair value range on NDQ units: $60 to $68 over 12 months, assuming earnings delivery and a stable multiple
•Downside case: $50 to $54 if AI capex disappoints and the multiple compresses to 24x
•IVV (S&P 500): ~22x NTM P/E, broad US large cap, lower tech concentration
•VGS (global ex Australia): ~20x NTM P/E, diversified developed markets
•VAS (ASX 300): ~17x NTM P/E, domestic, financials and materials heavy
•QQQ (US listed Nasdaq 100): same index, ~28x to 30x NTM P/E, USD exposure
•HNDQ (hedged Nasdaq 100): same index, removes FX, lower volatility for AUD investors

Key Risks & Catalysts

Risks

•Valuation risk: a 28x to 30x forward multiple leaves little room for earnings misses.
•Concentration risk: top holdings dominate the index, so single name weakness has outsized impact.
•AI capex digestion: if hyperscaler spending slows, semis and infrastructure names de rate sharply.
•Currency risk: unhedged USD exposure means a stronger AUD erodes returns.
•Rate sensitivity: long duration growth equities are vulnerable to sticky inflation and higher bond yields.
•Regulatory and antitrust risk across mega cap platforms.
•Tracking and cost drag from the 0.48% management cost over long horizons.

Catalysts

•Continued AI monetisation across cloud, software and advertising.
•Strong mega cap earnings beats lifting forward EPS estimates.
•Rate cuts supporting multiple expansion for long duration growth.
•Index rebalances adding high growth constituents.
•Sustained fund inflows reinforcing scale and liquidity.
•A weaker AUD providing a tailwind to unhedged returns.

Investment Thesis

NDQ is the cleanest ASX listed vehicle for owning the global AI and mega cap technology theme. The fund is large, liquid and efficiently tracks the Nasdaq 100, and its 58.2% technology weighting captures the structural earnings power of the dominant platform companies. For an investor seeking growth beta with a long horizon, the strategic case is intact.

The issue is price. At ~28x to 30x forward earnings the underlying index embeds significant optimism, and NDQ at $63.61 sits near the top of its 52 week range after a strong run. Forward returns will be driven by earnings delivery rather than multiple expansion, and the unhedged currency overlay adds a second variable for AUD investors. This is a hold, not a chase, at current levels.

Recommendation: Hold. Accumulate on weakness toward $55 to $58, which would bring the forward multiple back toward a more comfortable entry. Fair value range $60 to $68 over 12 months. Investors wanting the same exposure with less FX volatility should consider the hedged equivalent.

Written by Buy Side Bro's AI analyst from financials, consensus, filings and recent news. General information only, not financial advice.

Run your own analysis free

Buy Side Bro writes a note like this on any US, ASX or global stock in a few minutes: the thesis, valuation, catalysts, risks and a Buy, Hold or Sell call with a 12-month target. It comes with the daily market wrap, live markets, earnings and charts. Sign in and you get 7 days of full access free, no card needed.

iPhone app coming soon. The same account and subscription carry over.

See the latest research on other stocks